Cyclosporin in less common immune-mediated skin diseases.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 8881904.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cyclosporin represents a major step forward in the systemic treatment of various dermatoses. Psoriasis vulgaris and atopic eczema, the two major indications for the drug, are dealt with elsewhere in this issue. Therefore, this short review will focus on less common inflammatory skin diseases.
Medical subject headings
- Cyclosporine
- Dermatologic Agents
- Immune System Diseases
- Skin Diseases